St. Jude Children’s Research Hospital is one of the world’s premier research and treatment centers for childhood cancer. With unique clinical trials, innovative science and comprehensive patient care, our physicians and researchers are defining new frontiers in pediatric oncology.
Treatment Information
Meet Our Patients
We treat the toughest cases.
-
Leukemia and Lymphoma: The TOTAL Package
A new precision medicine study aims to push leukemia and lymphoma survival rates ever higher while reducing side effects.
-
Saving Eyes and Lives Worldwide
St. Jude harnesses technology to aid in the early detection and diagnosis of the eye cancer retinoblastoma.
-
Scientific Sleuths Solve Medical Mystery
St. Jude scientists investigate a genetic mutation that rendered a bacteria antibiotic-tolerant. In finding the cure, they may save more lives.
-
The Early Childhood Clinic: A Second Chance at a First Start
The St. Jude Early Childhood Clinic helps babies and toddlers achieve developmental milestones during treatment.
-
The Best Day Possible
The St. Jude Quality of Life for All team goes above and beyond to improve patients’ psychosocial, emotional, and symptom concerns.
-
Patients Pay it Forward
St. Jude Child Life unites five patients and inspires them to help one another persevere.
Comprehensive Cancer Center
St. Jude is the first and only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children.
Innovative Clinical Trials
St. Jude develops more oncology clinical trials than any other U.S. children's hospital. Armed with leading-edge research, superb resources, and a strongly collaborative culture, we translate laboratory discoveries into new options for children with tough-to-treat cancers.
Pediatric Cancer Genome Project
The roots of pediatric cancer are hidden deep within a child’s DNA. The St. Jude—Washington University Pediatric Cancer Genome Project is the world’s most ambitious effort to discover the origins of childhood cancer and seek new cures.
Cancer Survivorship Research
Improved treatments for childhood cancer have helped swell the ranks of survivors to more than 425,000 individuals nationwide. St. Jude is pioneering the field of cancer survivorship with major research programs that follow thousands of survivors for decades after their treatment.
Latest Oncology Research
-
Leukemia and Lymphoma: The TOTAL Package
A new precision medicine study aims to push leukemia and lymphoma survival rates ever higher while reducing side effects.
-
A Plan Unfolds for Accelerating Progress
James R. Downing, MD, president and chief executive officer, is heading a six-year, $7 billion strategy to accelerate progress toward curing childhood cancer.
-
St. Jude Biorepository: A Hope Chest of Cells
St. Jude patients donate tissue to the biorepository in hopes that their preserved biological samples will be used in groundbreaking cancer research.
-
ASCO 2017 will feature research from a variety of St. Jude experts
St. Jude experts present pediatric oncology and survivorship research at the annual meeting of the American Society of Clinical Oncology.
-
Saving Eyes and Lives Worldwide
St. Jude harnesses technology to aid in the early detection and diagnosis of the eye cancer retinoblastoma.
-
Scientific Sleuths Solve Medical Mystery
St. Jude scientists investigate a genetic mutation that rendered a bacteria antibiotic-tolerant. In finding the cure, they may save more lives.
-
Biostatisticians build a better analytic tool
Researchers craft a new approach for mining genomic data for rare genetic variations that may play a role in disease risk.
-
Genetic change reveals precision medicine possibilities for a high-risk leukemia
A possible targeted therapy is found for a high-risk form of acute lymphoblastic leukemia, the most common childhood cancer.
-
Researchers reveal genomic landscape of core-binding factor acute myeloid leukemia
Research from the Pediatric Cancer Genome Project identifies genomic landscape that contributes to the diversity of core-binding factor acute myeloid leukemia.
-
Genetic hallmarks of acute lymphoblastic leukemia subtype uncovered
Research from the Pediatric Cancer Genome Project identifies the mechanism of action for two transcription factors underlying a type of B-precursor acute lymphoblastic leukemia.
-
Advances in saving lives and sight
Incorporating topotecan into front-line therapy of advanced localized retinoblastoma cures patients and improves survival of eyes with useful vision.
-
Finding new ways to protect patients during chemo
Newly identified type of lung macrophage protects chemotherapy-treated mice from lethal bacterial pneumonia despite absence of neutrophils.
-
Stem cell propagation fuels cancer risk in different organs
St. Jude researchers provide experimental evidence to demonstrate how stem cells contribute to cancer risk.
-
Novel statistical method captures long-term health burden of pediatric cancer cures
Researchers develop “cumulative burden” statistical method to measure and address the impact of chronic disease in childhood cancer survivors
-
Some adolescent cancer survivors may require more comprehensive mental health screening
Study shows that most teen cancer survivors do well psychologically, but cancer treatment may influence some survivors’ symptoms
